Cancer Division
"A través de una investigación innovadora y de vanguardia aspiramos a transformar la sociedad aportando conocimientos y estrategias que mejoren la vida de los pacientes con cáncer"
DR. RUBÉN PÍO OSÉS
In the Cancer Division, we study the molecular and cellular processes that lead to the appearance of cancer and its spread through the organism via metastasis.
Our research is oriented towards real clinical needs and is integrated into the Research Areas of the Cancer Center Clínica Universidad de Navarra (CCUN).
The scientific activity of the Cancer Division is based on the work of its multidisciplinary and translational research groups. Our teams include professionals who are international references in their field, both at translational and clinical levels. We are also committed to differential technology, with unique and cutting-edge analytical methods and models.
For our research to have an impact, we actively participate in collaborative networks and national and international consortia, such as IdisNA, CIBERONC, I-ELCAP, GEM or PETHEMA. We also collaborate with the pharmaceutical industry through programs such as Partners of Choice, OTSP or imCORE, which facilitates translating our research into clinical trials.
Our research aim is to develop early diagnosis and treatment strategies accompanied by predictive markers of response or resistance that allow more personalized clinical management of the oncology patient.
Rubén Pío
DIVISION DIRECTOR
| +34 948 194 700 | Ext. 812020 | |
| rpio@unav.es | |
| Researcher profile |
Cancer Division Objectives
Study the mechanisms of malignant transformation, determine the risk of developing a malignant tumour and identify early detection strategies.
To study the mechanisms of resistance to treatment, detection of minimal residual disease and early intervention.
To analyze the impact of the tumour microenvironment, with special attention to the immune system, in the development of cancer and in the efficacy of antitumor treatments.
Identificar nuevas dianas y
desarrollar nuevas estrategias terapéuticas.
Our research groups
The Cancer Division is structured in three research programs
We investigate the main haematological tumours and those with great social impacts, such as leukaemias, lymphomas and myelomas.
Felipe Prósper and Bruno Paiva
Program Directors
We investigate major respiratory tract tumours, liver and pancreatic tumours, pediatric sarcomas and brain tumours, and gynaecological tumours.
Marta Alonso and Matías Ávila
Program Directors
We study new strategies that modulate the immune response to develop more effective antitumor therapies.
Juan José Lasarte and Ignacio Melero
Program Directors
Cancers we investigate
HEMATOLOGICAL TUMORS
SOLID TUMORS
Transforming society through
cancer cure
Cima's research is integrated into the activity of the Cancer Center Clínica Universidad de Navarra,
a centre of reference in cancer patients' care, research and teaching.
Learn more about our research
Get to know our research and research and technological support units